| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 3,886.0 | 3,764.0 |
| Gross profit | 2,314.0 | 2,226.0 |
| Profit before tax | 609.0 | 526.0 |
| Net income | 430.0 | 398.0 |
| EPS (diluted, $ a share) | $0.22 | $0.21 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Net income, year on year | +8.0% |
|---|---|
| Revenue, year on year | +3.2% |
| Gross margin | 59.5% |
| Operating margin | 18.2% |
10-Q filed with the SEC, NYSE: KVUE. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Kenvue Inc.: key numbers
- Share price
- $19.31Close, Oct 30
- Market cap
- $37.1B
- Shares outstanding
- 1.92BLatest SEC cover page
- Sector
- Life Sciences
- Industry
- Perfumes, Cosmetics & Other Toilet PreparationsSIC 2844
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Kenvue Inc.
All →Kenvue $7B Debt Financing with Kimberly-Clark Corporation
Kimberly-Clark Corporation completed exchange offers for up to $7 billion of Kenvue LLC's outstanding senior notes in exchange for new Kimberly-Clark notes and cash. As part of the settlement, Kenvue retired and canceled approximately $6.38 billion in aggregate principal amount of its notes across seven different series and implemented amendments to eliminate substantially all restrictive covenants in the remaining outstanding notes.
- Value
- $7B
- Counterparty
- Kimberly-Clark Corporation
Kenvue M&A Deal with Kimberly-Clark Corporation
Kenvue Inc. completed its merger with Kimberly-Clark Corporation, with Kenvue surviving as a direct wholly owned subsidiary of Kimberly-Clark. Under the terms of the agreement, Kenvue shareholders received $3.50 in cash and 0.14625 shares of Kimberly-Clark common stock for each share of Kenvue common stock held. In connection with the closing, Kenvue terminated its $4.0 billion revolving credit facility and its existing long-term incentive plans.
- Counterparty
- Kimberly-Clark Corporation
Kenvue Financial Results
Kenvue Inc. reported its third quarter 2026 financial results, delivering its fourth consecutive quarter of growth with net sales increasing 3.2% to $3.9 billion and organic sales up 2.9%. The company saw margin expansion and adjusted diluted EPS of $0.29, while noting it is nearing the completion of its combination with Kimberly-Clark.
- Term
- Q3 2026
“We are pleased to have delivered our fourth consecutive quarter of net and organic sales growth, with strong performance in Self Care and Essential Health, along with margin expansion and strong cash generation.”
Kirk Perry, Chief Executive Officer
“As we near the completion of our value-creating combination with Kimberly-Clark and bring together our two companies, the team is excited about the opportunities ahead.”
Kirk Perry, Chief Executive Officer
Kenvue Signs $7B M&A Deal with Kimberly-Clark Corporation
Kenvue Inc. entered into a supplemental indenture to amend existing senior notes in connection with its pending acquisition by Kimberly-Clark Corporation. The amendments, which eliminate restrictive covenants and reporting requirements, are tied to an exchange offer where Kimberly-Clark will issue up to $7 billion in new notes to replace Kenvue's existing debt.
- Value
- $7B
- Counterparty
- Kimberly-Clark Corporation